FindTrial
Sign In

Multicenter real-world study on clinicopathological features of follicular dendritic cell-derived tumors

Multicenter real-world study on clinicopathological features of follicular dendritic cell-derived tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400094891
Enrollment
Unknown
Registered
2024-12-30
Start date
2025-01-01
Completion date
Unknown
Last updated
2025-01-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Follicular dendritic cell-derived tumor

Interventions

Follicular dendritic cell sarcoma:None
EBV+ inflammatory follicular dendritic cell sarcoma:None

Sponsors

The First Affiliated Hospital of Army Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) A definite diagnosis of follicular dendritic cell sarcoma; (2) The date of diagnosis is January 2010-December 2025; (3) Age at least 18 years old at the time of diagnosis, gender is not limited; (4) Diagnosis in the center of the institution, supported by immunohistochemistry results; (5) Tissue wax blocks or tissue white sheets are stored in the center.

Exclusion criteria

Exclusion criteria: 1) Cases with unclear or doubtful diagnosis; 2) Only medical records, no pathological diagnosis information; 3) Consultation cases without pathological sections.

Design outcomes

Primary

MeasureTime frame
Progression-Free Survival;—

Secondary

MeasureTime frame
Overall Survival;—

Countries

China

Contacts

Public ContactGuangjie Duan

The First Affiliated Hospital of Army Medical University

gjduan@163.com+86 23 68766643

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026